ChemicalBook >> journal list >> Chemical Research in Toxicology >>article
Chemical Research in Toxicology

Chemical Research in Toxicology

IF: 3.7
Download PDF

2,2′,4,4′-Tetrabromodiphenyl Ether (PBDE 47) Selectively Stimulates Proatherogenic PPARγ Signatures in Human THP-1 Macrophages to Contribute to Foam Cell Formation

Published:16 May 2022 DOI: 10.1021/acs.chemrestox.2c00043
Qidong Ren, Xinni Xie*, Chuanfang Zhao, Qing Wen, Ruiying Pan and Yuguo Du*, 

Abstract

2,2′,4,4′-Tetrabromodiphenyl ether (PBDE 47) is one of the most prominent PBDE congeners detected in the human body, suggesting that the potential health risks of PBDE 47 should be thoroughly considered. However, the cardiovascular toxicity of PBDE 47 remains poorly understood. Here, toxic outcomes of PBDE 47 in human THP-1 macrophages concerning foam cell formation, which play crucial roles in the occurrence and development of atherosclerosis, were elucidated. First, our results indicated that PBDE 47 affected the PPARγ pathway most efficiently in THP-1 macrophages by transcriptomic analysis. Second, the PPARγ target genes CD36 and FABP4, responsible for lipid uptake and accumulation in macrophages, were consistently upregulated both at transcriptional and translational levels in THP-1 macrophages upon PBDE 47. Unexpectedly, PBDE 47 failed to activate the PPARγ target gene LXRα and PPARγ-LXRα-ABCA1/G1 cascade, which is activated by the PPARγ full agonist rosiglitazone and enables cholesterol efflux in macrophages. Thus, coincident with the selective upregulation of the PPARγ target genes CD36 and FABP4, PBDE 47, distinct from rosiglitazone, functionally resulted in more lipid accumulation and oxLDL uptake in THP-1 macrophages through high-content analysis (HCA). Moreover, these effects were markedly abrogated by the addition of the PPARγ antagonist T0070907. Mechanistically, the structural basis of selective activation of PPARγ by PBDE 47 was explored by molecular docking and dynamics simulation, which indicated that PBDE 47 interacted with the PPARγ ligand binding domain (PPARγ-LBD) distinctively from that of rosiglitazone. PBDE 47 was revealed to interact with helix 3 and helix 5 but not helix 12 in the PPARγ-LBD. Collectively, these results unraveled the potential cardiovascular toxicity of PBDE 47 by selective activation of PPARγ to facilitate foam cell formation for the first time.

Substances (11)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Bexarotene 153559-49-0 C24H28O2 347 suppliers $31.00-$1995.00
Bexarotene 153559-49-0 C24H28O2 347 suppliers $31.00-$1995.00
GW-501516 317318-70-0 C21H18F3NO3S2 268 suppliers $30.00-$1960.00
GW-501516 317318-70-0 C21H18F3NO3S2 268 suppliers $30.00-$1960.00
WY-14643 50892-23-4 C14H14ClN3O2S 213 suppliers $13.00-$912.90
WY-14643 50892-23-4 C14H14ClN3O2S 213 suppliers $13.00-$912.90
T0070907 313516-66-4 C12H8ClN3O3 169 suppliers $6.00-$1593.90
T0070907 313516-66-4 C12H8ClN3O3 169 suppliers $6.00-$1593.90
GW501516 317318-70-0 C21H18F3NO3S2 - Inquiry
GW501516 317318-70-0 C21H18F3NO3S2 - Inquiry